Pressmeddelanden, rapporter och bolagsmeddelande för Terveystalo Oyj

Terveystalo Plc reported a managers' transaction involving Rettig Investment AB, which is closely associated with Matts Rosenberg, a member of Terveystalo's Board. The transaction, dated June 27, 2024, involved the acquisition of 21,153,191 shares at a unit price of 0 EUR. This internal restructuring resulted from the merger of Rettig Group AB into Rettig Investment AB, transferring the shares to Rettig Investment AB. The notification was distributed to Nasdaq Helsinki Oy and principal media.

On 28 June 2024, Terveystalo Plc announced that Rettig Investment AB's ownership in Terveystalo has increased to 16.65%, comprising 21,153,191 shares out of a total of 127,036,531 shares. This change occurred due to an internal restructuring where Rettig Group AB merged into Rettig Investment AB on 27 June 2024, transferring the shares accordingly. Terveystalo is the largest private healthcare provider in Finland and a leading occupational health provider in the Nordic region, with extensive digital and physical services. The company is listed on the Helsinki Stock Exchange and employs over 15,500 professionals.

In Q1 2024, Terveystalo Plc reported strong performance with a 3% increase in revenue to EUR 350 million and a nearly 30% rise in adjusted EBITA to EUR 47 million. Healthcare Services, the company's core business, drove this growth with a revenue increase of over 7% to EUR 268 million. Despite challenges in the Swedish market, the company met its profit improvement program target of EUR 50 million ahead of schedule. For 2024, Terveystalo expects its revenue to grow and its adjusted EBITA margin to be between 10.5 and 11.5 percent. The company plans to continue focusing on operational efficiency and aims to reach an EBITA target of 12% in 2025.